SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015025
Filing Date
2021-11-08
Accepted
2021-11-08 16:06:26
Documents
71
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20210930x10q.htm   iXBRL 10-Q 1800023
2 EX-31.1 idra-20210930xex31d1.htm EX-31.1 14061
3 EX-31.2 idra-20210930xex31d2.htm EX-31.2 13771
4 EX-32.1 idra-20210930xex32d1.htm EX-32.1 7148
5 EX-32.2 idra-20210930xex32d2.htm EX-32.2 7757
6 GRAPHIC idra-20210930x10q004.jpg GRAPHIC 7407
7 GRAPHIC idra-20210930x10q012.jpg GRAPHIC 4117
8 GRAPHIC idra-20210930x10q013.jpg GRAPHIC 3734
  Complete submission text file 0001558370-21-015025.txt   7632908

Data Files

Seq Description Document Type Size
9 EX-101.SCH idra-20210930.xsd EX-101.SCH 50120
10 EX-101.CAL idra-20210930_cal.xml EX-101.CAL 40040
11 EX-101.DEF idra-20210930_def.xml EX-101.DEF 210851
12 EX-101.LAB idra-20210930_lab.xml EX-101.LAB 393722
13 EX-101.PRE idra-20210930_pre.xml EX-101.PRE 342688
14 EXTRACTED XBRL INSTANCE DOCUMENT idra-20210930x10q_htm.xml XML 1496907
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 211387935
SIC: 2836 Biological Products, (No Diagnostic Substances)